Thanks to advances in sequencing technologies, generating high-quality multiple omics data is now easier than ever. The boom in data collection means we can couple multiple omics techniques to build a more holistic picture of diseases and gain better biological insights into tissues or systems. However, making sense of the data remains a challenge. In this webinar series, we will present the very latest technologies and approaches that you can use to drive your own multi-omics studies forward.
This webinar series will:
- Help you build a holistic picture using single-cell and spatial multi-omics approaches
- Show you how to dissect complex diseases and pinpoint causative changes using multi-omics approaches
- Showcase examples of how big pharma companies are using multi-omics for drug discovery
Plus, each session will include live Q&A with the speakers.
** Please note, by registering for one webinar in the series you will automatically receive access to the subsequent webinar. **
– – – – –
Tuesday 17 January at 3pm GMT/ 4pm CET/ 10am EST
This webinar will highlight case studies of how the latest single-cell and spatial multi-omics approaches can best be applied, and what this means for your research going forward.
Talk 1: Beyond single cells: Subcellular single organelle spatial ‘omics
James Eberwine, Elmer Holmes Bobst Professor of Systems Pharmacology and Translational Therapeutics, Co-Director Penn Program in Single Cell Biology, Co-Director Penn Center for Subcellular Biology, University of Pennsylvania Perelman School of Medicine
Talk 2: Multi-omics studies of the molecular evolution of glioblastoma
P.J. (Pim) French, Associate Professor, Erasmus MC
Talk 3: Application of spatial omics techniques to study disease
Yang Liu, Assistant Professor of Pathology, Yale School of Medicine
– – – – –
Tuesday 24 January at 3pm GMT/ 4pm CET/ 10am EST
Researchers are increasingly turning to multi-omics to better connect phenotype to genotype and variant to function in the context of health and disease. By deconstructing diseases using multi-omics, we can deduce the pathways that are involved in disease – unlocking insights that can influence our ability to intercept disease onset. In this webinar, we will seek to better understand the intricate changes that cause disease in cells.
Talk 1: Using single-cell multi-omics to investigate the immune response to COVID-19
Emily Stephenson, Senior Research Associate, Newcastle University
Talk 2: Joint profiling of multi-omics within the same DNA molecules
Yaping Liu, Assistant Professor, Cincinnati Children’s Hospital Medical Cente
– – – – –
Tuesday 31 January at 3pm GMT/ 4pm CET/ 10am EST
Producing successful drugs that hit the market is dependent on a better understanding of the disease biology. With plenty of omics data to hand, how can we integrate these datasets to get the deepest insights faster? In this webinar, we will showcase data analysis examples from pharma using multi-omics for drug discovery.
Talk 1: Multi-omics in drug discovery
Philippe Sanseau, Senior Director of Computational Biology and Senior Fellow, GSK
Talk 2: Multi-omics approaches to inform disease mechanism and drug target identification
Andrew Jarnuczak, Associate Principal Scientist, AstraZeneca
– – – – –